Guía clínica chilena de urticaria crónica espontánea / Chilean guidelines for chronic urticaria
Rev. méd. Chile
;
146(11): 1334-1342, nov. 2018. tab, graf
Article
in Spanish
| LILACS
| ID: biblio-985707
RESUMEN
Chronic urticaria (CU) is characterized by itchy wheals, angioedema or both lasting six weeks or more. It is classified as spontaneous (CSU) and inducible urticaria (CIndU), depending whether there is an identifiable trigger or not. CSU is the predominant form, affecting more than 75% of patients, although overlaps often occur. The prevalence of CSU throughout life is around 1.8% and predominates in women at a ratio of 21. The higher incidence of CSU is between 20 and 40 years of age and lasts between one to five years. However, in up to 20% of patients the disease may last longer. CSU not only hampers quality of life, but also affect performance at work and school. The diagnosis of CSU is mainly clinical, and laboratory tests are required depending on the clinical history of the patient. Extensive laboratory tests are usually unnecessary. Second generation anti-histamines are used as first line treatment for CSU treatment. In refractory patients, systemic treatments, such as cyclosporine or omalizumab are suggested. We herein report the first Chilean CSU guidelines.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Urticaria
/
Practice Guidelines as Topic
Type of study:
Diagnostic study
/
Practice guideline
/
Prognostic study
/
Risk factors
Limits:
Humans
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2018
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Clínica Las Condes/CL
/
Clínica Santa María/CL
/
Hospital Sótero del Río/CL
/
Pontificia Universidad Católica de Chile/CL
/
Universidad de Chile/CL
Similar
MEDLINE
...
LILACS
LIS